What Are Compassionate Use and Expanded Access Programs?
For patients who have no other treatment options, the FDA provides pathways such as compassionate use and expanded access programs. These programs allow patients to access investigational drugs outside of clinical trials. Physicians can apply on behalf of their patients, and the FDA reviews these requests on a case-by-case basis.
